Ogawa K - Search Results

1

In Vivo Differences between Two Optical Isomers of Radioiodinated o-iodo-trans-decalinvesamicol for Use as a Radioligand for the Vesicular Acetylcholine Transporter.

Uno I, Kozaka T, Miwa D, Kitamura Y, Azim MA, Ogawa K, Taki J, Kinuya S, Shiba K. Uno I, et al. Among authors: ogawa k. PLoS One. 2016 Jan 11;11(1):e0146719. doi: 10.1371/journal.pone.0146719. eCollection 2016. PLoS One. 2016. PMID: 26752172 Free PMC article.

2

In vitro characterization of radioiodinated (+)-2-[4-(4-iodophenyl) piperidino]cyclohexanol [(+)-pIV] as a sigma-1 receptor ligand.

Shiba K, Ogawa K, Mori H. Shiba K, et al. Among authors: ogawa k. Bioorg Med Chem. 2005 Feb 15;13(4):1095-9. doi: 10.1016/j.bmc.2004.11.029. Bioorg Med Chem. 2005. PMID: 15670917

3

Synthesis and binding affinities of methylvesamicol analogs for the acetylcholine transporter and sigma receptor.

Shiba K, Ogawa K, Ishiwata K, Yajima K, Mori H. Shiba K, et al. Among authors: ogawa k. Bioorg Med Chem. 2006 Apr 15;14(8):2620-6. doi: 10.1016/j.bmc.2005.11.044. Epub 2006 Jan 24. Bioorg Med Chem. 2006. PMID: 16434200

4

A simple and rapid radiochemical choline acetyltransferase (ChAT) assay screening test.

Shiba K, Ogawa K, Kinuya S, Yajima K, Mori H. Shiba K, et al. Among authors: ogawa k. J Neurosci Methods. 2006 Oct 15;157(1):98-102. doi: 10.1016/j.jneumeth.2006.04.004. Epub 2006 May 12. J Neurosci Methods. 2006. PMID: 16698086

5

Therapeutic effects of a 186Re-complex-conjugated bisphosphonate for the palliation of metastatic bone pain in an animal model.

Ogawa K, Mukai T, Asano D, Kawashima H, Kinuya S, Shiba K, Hashimoto K, Mori H, Saji H. Ogawa K, et al. J Nucl Med. 2007 Jan;48(1):122-7. J Nucl Med. 2007. PMID: 17204708 Free article.

6

In vivo characterization of radioiodinated (+)-2-[4-(4-iodophenyl) piperidino] cyclohexanol as a potential sigma-1 receptor imaging agent.

Akhter N, Shiba K, Ogawa K, Kinuya S, Nakajima K, Mori H. Akhter N, et al. Among authors: ogawa k. Nucl Med Biol. 2007 Aug;34(6):697-702. doi: 10.1016/j.nucmedbio.2007.05.005. Nucl Med Biol. 2007. PMID: 17707810

7

A change of in vivo characteristics depending on specific activity of radioiodinated (+)-2-[4-(4-iodophenyl)piperidino]cyclohexanol [(+)-pIV] as a ligand for sigma receptor imaging.

Akhter N, Shiba K, Ogawa K, Tsuji S, Kinuya S, Nakajima K, Mori H. Akhter N, et al. Among authors: ogawa k. Nucl Med Biol. 2008 Jan;35(1):29-34. doi: 10.1016/j.nucmedbio.2007.09.005. Nucl Med Biol. 2008. PMID: 18158940

8

Usefulness of competitive inhibitors of protein binding for improving the pharmacokinetics of 186Re-MAG3-conjugated bisphosphonate (186Re-MAG3-HBP), an agent for treatment of painful bone metastases.

Ogawa K, Mukai T, Kawai K, Takamura N, Hanaoka H, Hashimoto K, Shiba K, Mori H, Saji H. Ogawa K, et al. Eur J Nucl Med Mol Imaging. 2009 Jan;36(1):115-21. doi: 10.1007/s00259-008-0925-8. Epub 2008 Aug 16. Eur J Nucl Med Mol Imaging. 2009. PMID: 18709369

9

Potential usefulness of D2R reporter gene imaging by IBF as gene therapy monitoring for cerebellar neurodegenerative diseases.

Shiba K, Torashima T, Hirai H, Ogawa K, Akhter N, Nakajima K, Kinuya S, Mori H. Shiba K, et al. Among authors: ogawa k. J Cereb Blood Flow Metab. 2009 Feb;29(2):434-40. doi: 10.1038/jcbfm.2008.137. Epub 2008 Nov 12. J Cereb Blood Flow Metab. 2009. PMID: 19002197

10

The potential of (-)-o-[11C]methylvesamicol for diagnosing cholinergic deficit dementia.

Shiba K, Nishiyama S, Tsukada H, Ishiwata K, Kawamura K, Ogawa K, Mori H. Shiba K, et al. Among authors: ogawa k. Synapse. 2009 Feb;63(2):167-71. doi: 10.1002/syn.20590. Synapse. 2009. PMID: 19021207

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,696 results

Search Page

Filters